EUVIMEDEUVIMED entdecken
Crossref

Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer

Lucia Lutat, Barbara Kreppel, Milka Marinova, Ingo G H Schmidt-Wolf, Carsten Meyer, Markus Essler

Nuklearmedizin - NuclearMedicine · 01.02.2026 · 65 (01) · 13-21

DOI: 10.1055/a-2738-2390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.02.2026. Verfasst von Lucia Lutat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Brachytherapy. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study aimed to investigate whether the differing biology of right-sided primary tumors (RSP) and left-sided primary tumors (LSP) in metastatic colorectal cancer (mCRC) affects survival outcomes following selective internal radiation therapy (SIRT). A cohort of 140 mCRC patients with liver metastases treated with SIRT between 2009 and 2016 was analyzed. Patients were stratified by tumor localization (RSP: proximal colon; LSP: distal colon and rectum), clinical, histopathological, and molecular data, were collected. Survival outcomes (OS and PFS) were evaluated using Kaplan-Meier analysis. Cox regression analysis identified independent predictors of survival, and subgroup analyses examined differences between RSP and LSP patients. Of the patients, 80.7% had LSP, and 19.3% had RSP. RSP patients demonstrated more aggressive tumor biology, with a higher frequency of poorly differentiated tumors (G3), extrahepatic metastases and K-RAS mutations. Median OS was significantly longer for LSP patients (7.0 months) compared to RSP patients (4.0 months, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsBrachytherapyHumansMaleFemaleMiddle AgedAgedRetrospective StudiesProgression-Free SurvivalSurvival RateAdultAged, 80 and overTreatment Outcome

Autor:innen und Institutionen

  • Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
  • Center for Integrated Oncology, University Hospital Bonn, Bonn, Germany.
  • Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.

Zitieren

APA

Lutat, L., Kreppel, B., Marinova, M., Schmidt-Wolf, I. G. H., Meyer, C., & Essler, M. (2026). Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer. Nuklearmedizin - NuclearMedicine, 65(01), 13-21. https://doi.org/10.1055/a-2738-2390

Vancouver

Lutat L, Kreppel B, Marinova M, Schmidt-Wolf IGH, Meyer C, Essler M. Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer. Nuklearmedizin - NuclearMedicine. 2026;65(01):13-21. doi:10.1055/a-2738-2390

BibTeX
@article{Lutat2026,
  author = {Lutat, Lucia and Kreppel, Barbara and Marinova, Milka and Schmidt-Wolf, Ingo G H and Meyer, Carsten and Essler, Markus},
  title = {Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {01},
  pages = {13--21},
  doi = {10.1055/a-2738-2390}
}
Kostenlos starten →